Drug intelligence / Profile preview

fluticasone propionate + formoterol fumarate

Development stage
Phase 3
Lead developer
Libbs Farmacêutica
Modality
Small Molecules
Administration
Inhalation
01

Overview

Duonare is a brand name for a fixed-dose combination (FDC) of fluticasone propionate and formoterol fumarate, developed by Libbs Pharmaceutical for the maintenance treatment of asthma in adults. Fluticasone propionate is an inhaled corticosteroid (ICS) that exerts potent anti-inflammatory effects by binding to glucocorticoid receptors in the airways, reducing swelling and irritation. Formoterol fumarate is a long-acting beta-2 adrenergic agonist (LABA) that provides rapid and sustained bronchodilation by relaxing airway smooth muscle. The product is delivered via a dry powder inhaler (DPI) and has been evaluated in clinical trials in Brazil, demonstrating comparable efficacy and safety to other established ICS/LABA combinations such as budesonide/formoterol.

Brand names
Duonare
Other names
fluticasone propionate/formoterol fumaratefluticasone/formoterol
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)PR (Progesterone receptor)ADRB1 (β1)ADRB2 (β2)ADRB3 (β3)

Beyond the preview

Go deeper on fluticasone propionate + formoterol fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluticasone propionate + formoterol fumarate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call